Publications 2017/2018 - Equipe 2

 
  • Galibert M, Wartenberg MLecaille FSaidi A, Mavel S, Joulin-Giet AKorkmaz B, Brömme D, Aucagne V, Delmas AF, Lalmanach G. Substrate-derived triazolo- and azapeptides as inhibitors of cathepsins K and S. Eur J Med Chem. 2017 Dec 7;144:201-210. doi: 10.1016/j.ejmech.2017.12.012
 
  • Guarino CHamon Y, Croix C, Lamort ASDallet-Choisy SMarchand-Adam S, Lesner A, Baranek T, Viaud-Massuard MC, Lauritzen C, Pedersen J, Heuzé-Vourc'h N, Si-Tahar M, Fıratlı E, Jenne DE, Gauthier F, Horwitz MS, Borregaard N, Korkmaz B. Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases. Biochem Pharmacol. 2017 Feb 10. pii: S0006-2952(17)30086-2. doi: 10.1016/j.bcp.2017.02.009.
 
  • Taggart C., Mall MA, Lalmanach G, Cataldo D, Ludwig A, Janciauskiene S, Heath N, Meiners S, Overall CM, Schultz C, Turk B, Borensztajn KS. Protean Proteases: at the cutting edge in lung diseases. Eur Respir J (2017) 49: 1501200. doi: 10.1183/13993003.01200-2015
 
  • Cottin V, Bel E, Bottero P, Dalhoff K, Humbert M, Lazor R, Sinico RA, Sivasothy P, Wechsler ME, Groh M, Marchand-Adam S, Khouatra C, Wallaert B, Taillé C, Delaval P, Cadranel J, Bonniaud P, Prévot G, Hirschi S, Gondouin A, Dunogué B, Chatté G, Briault C, Pagnoux C, Jayne D, Guillevin L, Cordier JF. Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Autoimmun Rev. 2017 Jan;16(1):1-9. doi: 10.1016/j.autrev.2016.09.018
 
  • Baranek T, Morello E, Valayer A, Aimar RF, Brea D, Henry C, Besnard AG, Dalloneau E, Guillon A, Dequin PF, Narni-Mancinelli E, Vivier E, Laurent F, Wei Y, Paget C, Si-Tahar M. FHL2 regulates natural killer cell development and activation during Streptococcus pneumoniae infection. Frontiers in Immunology (2017). doi: 10.3389/fimmu.2017.00123
 
  • A. Valayer, D. Bréa, L. Lajoie, L. Avezard, L. Combes-Soia, V. Labas, B. Korkmaz, G. Thibault, T. Baranek, M. Si-Tahar. Neutrophils can disarm NK cells response through cleavage of NKp46. J. Leukoc. Biol. (2017) 101, 253-259. doi: 10.1189/jlb.3AB0316-140RR
 
  • Magnen M, Gueugnon F, Guillon A, Baranek T, Thibault VC, Petit-Courty A, de Veer SJ, Harris J, Humbles AA, Si-Tahar M, Courty Y. Kallikrein-Related Peptidase 5 Contributes to H3N2 Influenza Virus Infection in Human Lungs.J Virol. (2017). Jul 27;91(16). doi: 10.1128/JVI.00421-17
 
  • Juge PA, Borie R, Kannengiesser C, Gazal, Revy P, Wémeau-Stervinou, L, Debray, MP, Ottaviani S, Marchand-Adam S, Nathan N; Thabut G, Richez C, Nunes H, Callebaut I, Justet A, Leulliot N, Bonnefond A, Salgado D, Richette P, Desvignes JP, Koubi-Lioté H, Froguel P, Allanore Y, Sand O, Dromer C, Flipo RM, Clement A, Beroud C, Sibilia J, Coustet B, Cottin V, Boissier MC, Wallaert B, Schaeverbeke T, Dastot Le Moal F, Frazier A, Menard C, Soubrier M, Saindenberg N, Valeyre D, Amselem S, Genin E, Boileau C, Crestani B, Dieude P. Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis. Eur Respir J. (2017). May 11;49(5). doi: 10.1183/13993003.02314-2016
 
  • Nattes E, Lejeune S, Carsin A, Borie R, Gibertini I, Balinotti J, Nathan N, Marchand-Adam S, Thumerelle C, Fauroux B, Bosdure E, Houdouin V, Delestrain C, Louha MK, Couderc R, De Becdelievre A, Fanen P, Funalot B, Crestani B, Deschildre A, Dubus JC, Epaud R. Heterogeneity of lung disease associated with NK2 homeobox 1 mutations. Respir Med. (2017) Aug;129:16-23. doi: 10.1016/j.rmed.2017.05.014
 
  • Sesé L, Nunes H, Cottin V, Sanyal S, Didier M, Carton Z, Israel-Biet D, Crestani B, Cadranel J, Wallaert B, Tazi A, Maître B, Prévot G, Marchand-Adam S, Guillot-Dudoret S, Nardi A, Dury S, Giraud V, Gondouin A, Juvin K, Borie R,Wislez M, Valeyre D, Annesi-Maesano I. Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis. Thorax. (2017) doi: 10.1136/thoraxjnl-2017-209967
 
  • Heidelberger V, Ingen-Housz-Oro S, Marquet A, Mahevas M, Bessis D, Bouillet L, Caux F, Chapelon-Abric C, Debarbieux S, Delaporte E, Duval-Modeste AB, Fain O, Joly P, Marchand-Adam S, Monfort JB, Noël N, Passeron T, Ruivard M, Sarrot-Reynauld F, Verrot D, Bouvry D, Fardet L, Chosidow O, Sève P, Valeyre D. Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases. JAMA Dermatol. (2017). Jul 1;153(7):681-685. doi: 10.1001/jamadermatol.2017.1162.
 
  • Paganin F, Mangiapan G, Proust A, Prudhomme A, Attia J, Marchand-Adam S, Pellet F, Milhe F, Melloni B, Bernady A, Raspaud C, Nocent C, Berger P, Guilleminault L. Lung function parameters in omalizumab responder patients: an interesting tool? Allergy. (2017) May 18. doi: 10.1111/all.13202